EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Incidence of venous thromboembolism and bleeding in patients with malignant central nervous system neoplasm: Systematic review and meta-analysis

Inzidenz von venöser Thromboembolie und Blutung bei Patienten mit malignem Tumor des zentralen Nervensystems: systematische Übersichtsarbeit und Metaanalyse

Viviane Cordeiro Veiga iD, Stela Verzinhasse Peres iD, Thatiane L V D P Ostolin, Flavia Regina Moraes, Talita Rantin Belucci, Carlos Afonso Clara, Alexandre Biasi Cavalcanti iD, Feres Eduardo Aparecido Chaddad-Neto, Gabriel N de Rezende Batistella iD, Iuri Santana Neville iD, Alex M Baeta, Camilla Akemi Felizardo Yamada und 1 weitere

PLOS ONE · 20.06.2024 · 19 (6) · e0304682

DOI: 10.1371/journal.pone.0304682 ↗

Auf einen Blick

Die Metaanalyse schätzt bei malignen ZNS-Neoplasien die gepoolte Inzidenz von VTE auf 13,68 % und von Blutung auf 11,60 %. Bei Patient:innen ab 60 Jahren war die VTE-Inzidenz am höchsten.

Fragestellung

Wie hoch ist die Inzidenz von VTE und Blutung bei Patient:innen mit malignen ZNS-Neoplasien?

Methode

Systematische Übersichtsarbeit und Metaanalyse; Suche in PubMed, Virtual Health Library und Cochrane bis Juli 2023; Random-effects-Modell mit Double-Arcsine-Transformation; Subgruppenanalysen.

Ergebnisse

36 Studien, überwiegend retrospektive Kohorten (n = 30). Gepoolte Inzidenz: VTE 13,68 % (95 %-KI 9,79; 18,79), Blutung 11,60 % (95 %-KI 6,16; 18,41). Bei ≥60-Jährigen: VTE 32,27 % (95 %-KI 14,40; 53,31).

Einschränkungen

Die Ergebnisse stammen hauptsächlich aus Studien aus Hochländern; die Autor:innen nennen weitere Forschung in Lateinamerika sowie in Ländern mit niedrigem und mittlerem Einkommen.

Schlussfolgerung der Autor:innen

Die gepoolte Inzidenz variierte für Gesamt- und Subgruppenanalysen. Bei über 60-Jährigen und bei GBM war die gepoolte VTE-Inzidenz höher; die meisten Daten stammen aus Hochländern.

Kernaussagen

  • VTE gepoolt: 13,68 % (95 %-KI 9,79; 18,79)
  • Blutung gepoolt: 11,60 % (95 %-KI 6,16; 18,41)
  • Höchste VTE-Inzidenz bei Patient:innen ab 60 Jahren

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 20.06.2024. Verfasst von Viviane Cordeiro Veiga und 12 weiteren Autor:innen. Beteiligte Einrichtung: BP-A Beneficência Portuguesa de São Paulo, São Paulo, Brasil. Hauptthemen laut MEDLINE: Venous Thromboembolism, Central Nervous System Neoplasms, Hemorrhage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PROADI - SUS. Ministério da Saúde, Brasil..

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Central nervous system (CNS) malignant neoplasms may lead to venous thromboembolism (VTE) and bleeding, which result in rehospitalization, morbidity and mortality. We aimed to assess the incidence of VTE and bleeding in this population.

Methods

This systematic review and meta-analysis (PROSPERO CRD42023423949) were based on a standardized search of PubMed, Virtual Health Library and Cochrane (n = 1653) in July 2023. After duplicate removal, data screening and collection were conducted by independent reviewers. The combined rates and 95% confidence intervals for the incidence of VTE and bleeding were calculated using the random effects model with double arcsine transformation. Subgroup analyses were performed based on sex, age, income, and type of tumor. Heterogeneity was calculated using Cochran’s Q test and I 2 statistics. Egger’s test and funnel graphs were used to assess publication bias.

Results

Only 36 studies were included, mainly retrospective cohorts (n = 30, 83.3%) from North America (n = 20). Most studies included were published in high-income countries. The sample size of studies varied between 34 and 21,384 adult patients, mostly based on gliomas (n = 30,045). For overall malignant primary CNS neoplasm, the pooled incidence was 13.68% (95%CI 9.79; 18.79) and 11.60% (95%CI 6.16; 18.41) for VTE and bleeding, respectively. The subgroup with elderly people aged 60 or over had the highest incidence of VTE (32.27% - 95%CI 14.40;53.31). The studies presented few biases, being mostly high quality. Despite some variability among the studies, we observed consistent results by performing sensitivity analysis, which highlight the robustness of our findings.

Conclusions

Our study showed variability in the pooled incidence for both overall events and subgroup analyses. It was highlighted that individuals over 60 years old or diagnosed with GBM had a higher pooled incidence of VTE among those with overall CNS malignancies. It is important to note that the results of this meta-analysis refer mainly to studies carried out in high-income countries. This highlights the need for additional research in Latin America, and low- and middle-income countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismCentral Nervous System NeoplasmsHemorrhageHumansIncidenceMaleFemale

Autor:innen und Institutionen

  • BP-A Beneficência Portuguesa de São Paulo, São Paulo, Brasil.
  • Hospital do Câncer de Barretos, São Paulo, Brasil.
  • HCor-Research Institute, São Paulo, Brasil.
  • Universidade Federal de São Paulo, São Paulo, Brasil.
  • Instituto do Câncer de São Paulo, São Paulo, Brasil.

ORCID-Profile: Viviane Cordeiro Veiga, Stela Verzinhasse Peres, Alexandre Biasi Cavalcanti, Gabriel N de Rezende Batistella, Iuri Santana Neville

Förderung

  • PROADI - SUS. Ministério da Saúde, Brasil.

Zitieren

APA

Veiga, V. C., Peres, S. V., Ostolin, T. L. V. D. P., Moraes, F. R., Belucci, T. R., Clara, C. A., Cavalcanti, A. B., Chaddad-Neto, F. E. A., Batistella, G. N. R., Neville, I. S., Baeta, A. M., Yamada, C. A. F., & TROMBOGLIO Study Group (2024). Incidence of venous thromboembolism and bleeding in patients with malignant central nervous system neoplasm: Systematic review and meta-analysis. PLOS ONE, 19(6), e0304682. https://doi.org/10.1371/journal.pone.0304682

Vancouver

Veiga VC, Peres SV, Ostolin TLVDP, Moraes FR, Belucci TR, Clara CA, et al. Incidence of venous thromboembolism and bleeding in patients with malignant central nervous system neoplasm: Systematic review and meta-analysis. PLOS ONE. 2024;19(6):e0304682. doi:10.1371/journal.pone.0304682

BibTeX
@article{Veiga2024,
  author = {Veiga, Viviane Cordeiro and Peres, Stela Verzinhasse and Ostolin, Thatiane L V D P and Moraes, Flavia Regina and Belucci, Talita Rantin and Clara, Carlos Afonso and Cavalcanti, Alexandre Biasi and Chaddad-Neto, Feres Eduardo Aparecido and Batistella, Gabriel N de Rezende and Neville, Iuri Santana and Baeta, Alex M and Yamada, Camilla Akemi Felizardo and TROMBOGLIO Study Group, TROMBOGLIO Study Group},
  title = {Incidence of venous thromboembolism and bleeding in patients with malignant central nervous system neoplasm: Systematic review and meta-analysis},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {6},
  pages = {e0304682},
  doi = {10.1371/journal.pone.0304682}
}
Kostenlos starten →